+143.3%
DELL vs MRNA
+945.0%
-801.7%
-36.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -8.8% | +13.1% | -21.9% | -8.7% |
| 7D | -24.6% | +20.6% | -45.2% | -24.4% |
| 30D | -32.5% | +27.1% | -59.6% | -32.2% |
| 3M | -20.2% | +353.4% | -373.6% | -19.0% |
| 6M | +76.5% | +446.3% | -369.8% | +70.1% |
| YTD | +198.9% | +776.2% | -577.2% | +170.3% |
| 1Y | +143.3% | +987.9% | -844.6% | +106.9% |
| All | +143.3% | +945.0% | -801.7% | +106.9% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling